Organovo Announces Release Date for Fiscal First-Quarter 2019 Financial Results
19 juil. 2018 08h05 HE
|
Organovo, Inc.
SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 9, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the...
Organovo Reports Fiscal Fourth-Quarter and Full-Year 2018 Results; Company Announces Key Goals for Fiscal-Year 2019
31 mai 2018 16h05 HE
|
Organovo, Inc.
- Lead Investigational New Drug (“IND”) program for Alpha-1-antitrypsin deficiency (“A1AT”) received FDA’s orphan drug designation and is on track for commencing IND-enabling studies in fiscal 2019 -...
Organovo Announces Release Date for Fiscal Fourth-Quarter 2018 Financial Results
14 mai 2018 08h05 HE
|
Organovo, Inc.
SAN DIEGO, May 14, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, May 31, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the...
Organovo to Present New Preclinical Data for Its Liver Therapeutic Tissue IND-Track Programs at the World Advanced Therapies and Regenerative Medicine Congress
10 mai 2018 08h05 HE
|
Organovo, Inc.
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will present new preclinical data showing the strong functionality of its liver...
Organovo and Samsara Sciences Partner with New Manufacturing USA Institute
03 mai 2018 08h05 HE
|
Organovo, Inc.
SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced it has joined a new public-private Manufacturing USA initiative, the Advanced...
Organovo to Present at 2nd Annual NASH Summit
24 avr. 2018 08h05 HE
|
Organovo, Inc.
SAN DIEGO, April 24, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will present at the 2nd Annual NASH Summit in Boston, Ma. on Tuesday, April...
Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models
16 avr. 2018 08h05 HE
|
Organovo, Inc.
SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that along with its collaborators, it has achieved several breakthrough capabilities...
Organovo Presents Data on Modeling Liver Disease Using 3D Bioprinted Human Liver Tissue at The International Liver Congress™
12 avr. 2018 08h05 HE
|
Organovo, Inc.
SAN DIEGO, April 12, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today presented data on modeling non-alcoholic fatty liver disease (“NAFLD”) using its 3D bioprinted...
Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions
26 mars 2018 08h05 HE
|
Organovo, Inc.
SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that its wholly-owned subsidiary, Samsara Sciences, Inc. (“Samsara”), a provider of...
Organovo to Present at H.C. Wainwright Nash Investor Conference
15 mars 2018 08h05 HE
|
Organovo, Inc.
SAN DIEGO, March 15, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that Chief Executive Officer Taylor J. Crouch is scheduled to speak at the H.C....